Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frazier

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
European Journal of Biochemistry|October 14, 2004
The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitiveLinda O'Reilly, Peter Bross, Thomas J Corydon, et al.
Journal of Inherited Metabolic Disease|July 23, 2003
Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screeningD D Koeberl, D S Millington, W E Smith, et al.
Environmental Health Perspectives|March 2, 2006
Workgroup report: Implementing a national occupational reproductive research agenda--decade one and beyondChristina C Lawson, Barbara Grajewski, George P Daston, et al.
American Journal of Human Genetics|May 12, 2001
Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiencyB S Andresen, S F Dobrowolski, L O'Reilly, et al.
The New England Journal of Medicine|January 25, 2018
Moving Ahead with a New NEJM.orgEdward W Campion, Lisa A Scott, John E Muenning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Molecular Genetics and Metabolism|May 24, 2016
Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approachRani H Singh, Amy C Cunningham, Shideh Mofidi, et al.
Journal of Psychiatry and Brain Science|November 20, 2020
The Role of Social Reward and Corticostriatal Connectivity in Substance UseDaniel Sazhin, Angelique M Frazier, Caleb R Haynes, et al.
Journal of Visualized Experiments : Jove|April 17, 2023
Magnetic Resonance-Guided Stereotaxy for Infusions to the Pig BrainJesus G Cruz-Garza, Khaled M Taghlabi, Lokeshwar S Bhenderu, et al.
Scientific Reports|February 18, 2018
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infectionGary P Wang, Norah Terrault, Jacqueline D Reeves, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Biochemistry|October 14, 2004
The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitiveLinda O'Reilly, Peter Bross, Thomas J Corydon, et al.
Journal of Inherited Metabolic Disease|July 23, 2003
Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screeningD D Koeberl, D S Millington, W E Smith, et al.
Environmental Health Perspectives|March 2, 2006
Workgroup report: Implementing a national occupational reproductive research agenda--decade one and beyondChristina C Lawson, Barbara Grajewski, George P Daston, et al.
American Journal of Human Genetics|May 12, 2001
Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiencyB S Andresen, S F Dobrowolski, L O'Reilly, et al.
The New England Journal of Medicine|January 25, 2018
Moving Ahead with a New NEJM.orgEdward W Campion, Lisa A Scott, John E Muenning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Molecular Genetics and Metabolism|May 24, 2016
Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approachRani H Singh, Amy C Cunningham, Shideh Mofidi, et al.
Journal of Psychiatry and Brain Science|November 20, 2020
The Role of Social Reward and Corticostriatal Connectivity in Substance UseDaniel Sazhin, Angelique M Frazier, Caleb R Haynes, et al.
Journal of Visualized Experiments : Jove|April 17, 2023
Magnetic Resonance-Guided Stereotaxy for Infusions to the Pig BrainJesus G Cruz-Garza, Khaled M Taghlabi, Lokeshwar S Bhenderu, et al.
Scientific Reports|February 18, 2018
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infectionGary P Wang, Norah Terrault, Jacqueline D Reeves, et al.
Pageof 24